Adherence to topical treatment in psoriasis: A systematic literature review

Journal of the European Academy of Dermatology and Venereology

Volumn 26, Issue SUPPL. 3, 2012, Pages 61-67

  Devaux, S ^a   Castela, A ^b   Archier, E ^c   Gallini, A ^d   Joly, P ^e   Misery, L ^f   Aractingi, S ^g   Aubin, F ^h   Bachelez, H ⁱ   Cribier, B ^j   Jullien, D ^k   Le Maitre M ^l   Richard, M A ^c   Ortonne, J P ^b   Paul, C ^a  

^a UNIVERSITÉ PAUL SABATIER   (France)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d UMR INSERM 1027   (France)

^e UNIVERSITÉ DE ROUEN   (France)

^f BREST UNIVERSITY HOSPITAL   (France)

^g HÔPITAL TENON   (France)

^h UNIVERSITÉ DE FRANCHE COMTÉ   (France)

ⁱ SAINT LOUIS HOSPITAL   (France)

^j UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^k EDOUARD HERRIOT HOSPITAL   (France)

^l NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPSORIASIS AGENT; COSMETIC;

AGE; DISEASE SEVERITY; HUMAN; MEDICAL INFORMATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSORIASIS; REVIEW; SEX DIFFERENCE; SOCIAL ASPECT; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT PLANNING;

ADMINISTRATION, TOPICAL; CLINICAL TRIALS AS TOPIC; DERMATOLOGIC AGENTS; HUMANS; PATIENT COMPLIANCE; PSORIASIS;

EID: 84860129814     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2012.04525.x     Document Type: Review

References (42)

1. Dubertret L, Mrowietz U, Ranki A, et al. European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey. Br J Dermatol 2006; 155: 729-736. (Pubitemid 44352553)
2. Meyer N, Paul C, Feneron D, et al. Psoriasis: an epidemiological evaluation of disease burden in 590 patients. J Eur Acad Dermatol Venereol 2010; 24: 1075-1082.
3. Kinney MA, Feldman SR,. What's new in the management of psoriasis? G Ital Dermatol Venereol 2009; 144: 103-117.
4. Devaux S, Castela A, Archier E, et al. Topical vitamin D analogues alone or in association with topical steroids for psoriasis: a systematic review. J Eur Acad Dermatol Venereol 2012; 26 (Suppl. 3): 52-60.
5. Serup J, Lindblad AK, Maroti M, et al. To follow or not to follow dermatological treatment-a review of the literature. Acta Derm Venereol 2006; 86: 193-197. (Pubitemid 43875201)
6. Carroll CL, Feldman SR, Camacho FT, Balkrishnan R,. Better medication adherence results in greater improvement in severity of psoriasis. Br J Dermatol 2004; 151: 895-897. (Pubitemid 39482127)
7. Osterberg L, Blaschke T,. Adherence to medication. N Engl J Med 2005; 4: 353.
8. Richards HL, Fortune DG, Griffiths CEM,. Adherence to treatment in patients with psoriasis. J Eur Acad Dermatol Venereol 2006; 20: 370-379.
9. C Paul, A Gallini, E Archier, et al. Evidence-based recommendations on topical treatments and phototherapy of psoriasis: systematic review and expert opinion of a panel of dermatologists. J Eur Acad Dermatol Venereol 2012; 26 (Suppl. 3): 1-10.
10. Balkrishnan R, Carroll CL, Camacho FT, Feldman SR,. Electronic monitoring of medication adherence in skin disease: results of a pilot study. J Am Acad Dermatol 2003; 49: 651-654. (Pubitemid 37210278)
11. Carroll CL, Feldman SR, Camacho FT, et al. Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use. J Am Acad Dermatol 2004; 51: 212-216.
12. Feldman SR, Camacho FT, Krejci-Manwaring J, Carroll CL, Balkrishnan R,. Adherence to topical therapy increases around the time of office visits. J Am Acad Dermatol 2007; 57: 81-83. (Pubitemid 46908856)
13. Brown KK, Rehmus WE, Kimball AB,. Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis. J Am Acad Dermatol 2006; 55: 607-613. (Pubitemid 44436629)
14. van de Kerkhof PC, Steegers-Theunissen RP, Kuipers MV,. Evaluation of topical drug treatment in psoriasis. Dermatology (Basel) 1998; 197: 31-36. (Pubitemid 28327834)
15. van de Kerkhof PC, de Hoop D, de Korte J, Cobelens SA, Kuipers MV,. Patient compliance and disease management in the treatment of psoriasis in the Netherlands. Dermatology (Basel) 2000; 200: 292-298. (Pubitemid 30451575)
16. van de Kerkhof PC, Franssen M, de La Brassine M, Kuipers M,. Calcipotriol cream in the morning and ointment in the evening: a novel regimen to improve compliance. J Dermatolog Treat 2001; 12: 75-79. (Pubitemid 33009885)
17. Fouéré S, Adjadj L, Pawin H,. How patients experience psoriasis: results from a European survey. J Eur Acad Dermatol Venereol 2005; 19 (Suppl. 3): 2-6. (Pubitemid 41726918)
18. Douglas WS, Poulin Y, Decroix J, et al. A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris. Acta Derm Venereol 2002; 82: 131-135. (Pubitemid 34596689)
19. Guenther L, Van de Kerkhof PCM, Snellman E, et al. Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial. Br J Dermatol 2002; 147: 316-323.
20. Kaufmann R, Bibby AJ, Bissonnette R, et al. A new calcipotriol/ betamethasone dipropionate formulation (Daivobet) is an effective once-daily treatment for psoriasis vulgaris. Dermatology (Basel) 2002; 205: 389-393. (Pubitemid 35356768)
21. Menter A, Abramovits W, Colõn LE, et al. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis. J Drugs Dermatol 2009; 8: 52-57.
22. White S, Vender R, Thaçi D, et al. Use of calcipotriene cream (Dovonex cream) following acute treatment of psoriasis vulgaris with the calcipotriene/betamethasone dipropionate two-compound product (Taclonex): a randomized, parallel-group clinical trial. Am J Clin Dermatol 2006; 7: 177-184. (Pubitemid 43845342)
23. Kragballe K, Noerrelund KL, Lui H, et al. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris. Br J Dermatol 2004; 150: 1167-1173. (Pubitemid 38932288)
24. Gokdemir G, Ari S, Köşlü A,. Adherence to treatment in patients with psoriasis vulgaris: Turkish experience. J Eur Acad Dermatol Venereol 2008; 22: 330-335. (Pubitemid 351247423)
25. Zaghloul SS, Goodfield MJD,. Objective assessment of compliance with psoriasis treatment. Arch Dermatol 2004; 140: 408-414. (Pubitemid 38469243)
26. Storm A, Benfeldt E, Andersen SE, Serup J,. A prospective study of patient adherence to topical treatments: 95% of patients underdose. J Am Acad Dermatol 2008; 59: 975-980.
27. Osborne JE, Hutchinson PE,. The importance of accurate dosage of topical agents: a method of estimating involved area and application to calcipotriol treatment failures. J Eur Acad Dermatol Venereol 2002; 16: 367-373. (Pubitemid 34918819)
28. Poyner TF, Menday AP, Williams ZV,. Patient attitudes to topical antipsoriatic treatment with calcipotriol and dithranol. J Eur Acad Dermatol Venereol 2000; 14: 153-158. (Pubitemid 32899287)
29. Richards HL, Fortune DG, O'Sullivan TM, et al. Patients with psoriasis and their compliance with medication. J Am Acad Dermatol 1999; 41: 581-583. (Pubitemid 29480408)
30. Kulkarni AS, Balkrishnan R, Camacho FT, et al. Medication and health care service utilization related to depressive symptoms in older adults with psoriasis. J Drugs Dermatol 2004; 3: 661-666.
31. Uhlenhake EE, Kurkowski D, Feldman SR,. Conversations on psoriasis-what patients want and what physicians can provide: a qualitative look at patient and physician expectations. J Dermatolog Treat 2010; 21: 6-12.
32. Ersser SJ, Cowdell FC, Latter SM, Healy E,. Self-management experiences in adults with mild-moderate psoriasis: an exploratory study and implications for improved support. Br J Dermatol 2010; 163: 1044-1049.
33. Feldman SR, Horn EJ, Balkrishnan R, et al. Psoriasis: improving adherence to topical therapy. J Am Acad Dermatol 2008; 59: 1009-1016.
34. De Geest S, Sabate E,. Adherence to long-term therapies: evidence for action. Eur J Cardiovasc Nurs 2003; 2: 323. (Pubitemid 37518223)
35. Augustin M, Holland B, Dartsch D, Langenbruch A, Radtke MA,. Adherence in the treatment of psoriasis: a systematic review. Dermatology [WWW document] 2011 juill 13 URL (last accessed: 2 September 2011).
36. Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T,. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 2004; 9: 136-139. (Pubitemid 38457271)
37. Richards HL, Fortune DG, O'Sullivan TM, et al. Patients with psoriasis and their compliance with medication. J Am Acad Dermatol 1999; 41: 581-583. (Pubitemid 29480408)
38. Balkrishnan R,. Predictors of medication adherence in the elderly. Clin Ther 1998; 20: 764-771. (Pubitemid 28421497)
39. Stone VE, Hogan JW, Schuman P, et al. Antiretroviral regimen complexity, self-reported adherence, and HIV patients' understanding of their regimens: survey of women in the her study. J Acquir Immune Defic Syndr 2001; 28: 124-131. (Pubitemid 32971059)
40. Claxton AJ, Cramer J, Pierce C,. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001; 23: 1296-1310. (Pubitemid 32804122)
41. Cramer J,. Identifying and improving compliance patterns. in:, Cramer JA, Spilker B, eds. Patient Compliance in Medical Practice and Clinical Trials. New York: Raven Press, 1991: 387-392.
42. Pouplard C, Gourraud P-A, Meyer N, et al. Are we giving patients enough information on how to use topical treatments? Analysis of 767 prescriptions in psoriasis. Br J Dermatol 2011; 165: 1332-1336.